Investigating the Clinical Consequences of Flutemetamol-PET-scanning
Stopped Insufficient Recruitment
Conditions
- Mild Cognitive Impairment
- Alzheimer's Disease
- Dementia
Interventions
- DRUG: Flutemetamol (Vizamyl)
Sponsor
University of Zurich
Collaborators